Retatrutide 32mg

Retatrutide is a next-generation "triple agonist" peptide targeting GLP-1, GIP, and Glucagon receptors simultaneously. While GLP-1 and GIP suppress appetite and stabilize blood sugar, the glucagon component directly increases resting metabolic expenditure—forcing your body to burn stored fat more efficiently even at rest.

Semaglutide targets 1 receptor (GLP-1) and Tirzepatide targets 2 (GLP-1 + GIP). Retatrutide is the world’s first triple-action mechanism. By adding Glucagon receptor activation, Retatrutide not only curbs cravings but also actively increases calorie burning, leading to faster fat loss with higher energy levels.

Absolutely. Many clients switch to Retatrutide after hitting a weight-loss plateau on single or dual agonists. Because Retatrutide activates a third metabolic pathway (glucagon), it breaks through plateaus and restarts rapid fat mobilization.

Appetite suppression typically begins within 24 to 48 hours after your first micro-dose. Noticeable changes in body composition, midsection waist reduction, and weight scale progress are generally seen within weeks 2 to 4 of consistent weekly use.

Retatrutide’s triple pathway preferentially mobilizes visceral fat over muscle tissue. However, to preserve maximum lean muscle density and tone, we recommend maintaining high daily protein intake, light resistance training, or pairing it with Somatropin HGH or CJC-1295 + Ipamorelin.

For first-time users, we recommend starting at a low titration dose (e.g., 2mg once weekly) for the first 4 weeks. This allows your digestive system to adapt smoothly before gradually scaling up to higher maintenance protocols.

Mild nausea, temporary fullness, or light digestive changes can happen during the initial titration phase. To eliminate side effects, stay hydrated with electrolytes, eat smaller nutrient-dense meals, and avoid high-fat foods on injection days.

Yes. Our Retatrutide comes in a precision multi-dose dial pen. There is no need for manual mixing, sterile reconstitution water, or complex vial math—simply select your dose and administer subcutaneously in seconds.

Depending on your target dose and where you are in your protocol (starter vs. maintenance dose), a single multi-dose pen provides between 4 to 8 weeks of continuous weekly support.

Retatrutide must be kept cold to preserve molecular stability. We ship all orders across Bali (Canggu, Pererenan, Seminyak, Ubud, Uluwatu) in specialized insulated cold-chain thermal packaging. Keep your pen refrigerated at 2°C–8°C upon arrival.